Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 10.515\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) COc1ccc(Oc2c(Cl)cnn(-c3ccc(F)cc3)c2=O)cc1
b.) Cc1ccc(NC(=O)CN2C(=O)NC(C)(C3CC3)C2=O)c([N+](=O)[O-])c1
c.) CN1CCN(S(=O)(=O)c2ccc(Br)c3nsnc23)CC1
d.) CCCc1[nH]n(-c2nc3ccccc3s2)c(=O)c1C=NCC(C)C
e.) CCc1cc[n+](C2=C([O-])c3ccccc3C(=O)/C2=N\S(=O)(=O)c2cccs2)cc1
Answer: c. CN1CCN(S(=O)(=O)c2ccc(Br)c3nsnc23)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN1CCN(S(=O)(=O)c2ccc(Br)c3nsnc23)CC1
CN1CCN(S(=O)(=O)c2ccc(Br)c3nsnc23)CC1
4-bromo-7-(4-methylpiperazin-1-yl)sulfonyl-2,1,3-benzothiadiazole